Condie Carmack
AeroLeads people directory · profile

Condie Carmack Email & Phone Number

Owner and Entrepreneur
Location: Greater Houston, United States 9 work roles 4 schools
LinkedIn matched
✓ Verified August 2026 3 data sources Profile completeness 71%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Role
Owner and Entrepreneur
Location
Greater Houston, United States

Who is Condie Carmack? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Condie Carmack is listed as Owner and Entrepreneur based in Greater Houston, United States. AeroLeads shows a matched LinkedIn profile for Condie Carmack.

Condie Carmack previously worked as Diagnostics Medical Science Liaison at Loxo Oncology, Inc. and Vice President of Precision Oncology at Vela Diagnostics. Condie Carmack holds Doctor Of Philosophy (Ph.D.), Pathology/Experimental Pathology from University Of Utah School Of Medicine.

Profile bio

About Condie Carmack

Condie Carmack is a Owner and Entrepreneur. Colleagues describe them as "Condie has built and is continuing to build a very successful business within Agilent, focussed on leveraging Agilent's microarray expertise into diagnostics. He is accomplishing this by growing and maintaining an extensive network of personal contacts within the Comparative Genomic Hybridization community. Truly someone who 'acts like an owner' in his pursuit of company goals."

9 roles · 47 years

Condie Carmack work experience

A career timeline built from the work history available for this profile.

Vice President Of Precision Oncology

Fairfield, Nj

Nov 2016 - Apr 2018

Director Of Oncology Programs - R&D

Houston, Texas Area

Oversaw cutting-edge research & development efforts with responsibility for conceptualizing and designing revolutionary Next Generation Sequencing (NGS) and qPCR tests.Cultivated relationships with top molecular pathology laboratories and scientists to understand research goals, develop solutions, integrate new technology, and validate design, performance, and regulatory claims of tests. Compiled and prioritized lists of genes to provide vital information to clients. Managed laboratory… Show more Oversaw cutting-edge research & development efforts with responsibility for conceptualizing and designing revolutionary Next Generation Sequencing (NGS) and qPCR tests.Cultivated relationships with top molecular pathology laboratories and scientists to understand research goals, develop solutions, integrate new technology, and validate design, performance, and regulatory claims of tests. Compiled and prioritized lists of genes to provide vital information to clients. Managed laboratory technicians; assisted in resolving bench-level science issues.Selected Contributions:♦ Succeeded in designing four NGS oncology tests, created control reference material, and drafted submission to FDA to obtain premarket approval (PMA) for a Companion Diagnostic (CDx). Show less

Jan 2013 - Feb 2015

General Manager, Cancer Genetics Laboratory

Houston, Texas Area

Led start-up operations and financial performance for CLIA-certified and CAP-accredited laboratory developing groundbreaking oncology tests.Interfaced with laboratory director, technicians, and business colleagues to design and develop tests meeting strict regulatory requirements. Seeded databases and prepared documentation. Recruited, hired, and integrated 20-member team. Managed relationships with vendors and procured equipment. Oversaw all marketing efforts to promote lab and tests… Show more Led start-up operations and financial performance for CLIA-certified and CAP-accredited laboratory developing groundbreaking oncology tests.Interfaced with laboratory director, technicians, and business colleagues to design and develop tests meeting strict regulatory requirements. Seeded databases and prepared documentation. Recruited, hired, and integrated 20-member team. Managed relationships with vendors and procured equipment. Oversaw all marketing efforts to promote lab and tests. Tracked financial and sales data to adjust marketing strategies, reimbursement structure, and staffing as needed.Selected Contributions:♦ Developed and marketed 140 LDT cancer tests within first year and offered groundbreaking NGS oncology panel test in the United States under LDT/CLIA/CAP.♦ Provided effective leadership to enable laboratory to break even within two years with $5M in business. Show less

Oct 2010 - Dec 2012

Worldwide Molecular Diagnostic Manager

Santa Clara, Ca

Led development of $25M market in cytogenetics converting karyotype into microarrays and navigated complex FDA/LDT requirements to market and sell to cytogenetic labs.Engaged with cytogenetic laboratories to evaluate products, prepared product technical notes, and oversaw demonstration laboratory. Directed clinical research collaborations with top universities. Coached sales team on products, clinical diagnostics, sales pitches, and FDA/CLIA compliance issues. Maintained and operated… Show more Led development of $25M market in cytogenetics converting karyotype into microarrays and navigated complex FDA/LDT requirements to market and sell to cytogenetic labs.Engaged with cytogenetic laboratories to evaluate products, prepared product technical notes, and oversaw demonstration laboratory. Directed clinical research collaborations with top universities. Coached sales team on products, clinical diagnostics, sales pitches, and FDA/CLIA compliance issues. Maintained and operated laboratory equipment. Documented and published new techniques. Received two University Relations Grants.Selected Contributions:♦ Pioneered entry into clinical diagnostics, demonstrated value proposition, and gained full support from leadership team.♦ Initiated and led development and launch of eArray Web site and CytoGenomics software still in use and profitable today.♦ Successfully grew market by 25% year-over-year for four years; led development of 50+ clinical arrays, introduced 11 RUO products/reagents, and managed royalty payments on two color array CGH for clinical applications.♦ Spearheaded innovative marketing strategies, including “RockStar” Marketing Program for clinical cytogeneticists to share array content under LDT.♦ Served as relationship manager and coordinator for International Standard Cytogenetic Array Consortium (ISCA), Cancer Cytogenomics Microarray Consortium (CCMC), NIH/Columbia Prenatal Multi-Center Array Grant, and Agendia, BV and Agendia, Inc.♦ Received distinction as Invited Chairman and Speaker at BIT’s 1st Annual Congress and Expo of Molecular Diagnostics (10/08).♦ Held contracted positions as Product and Marketing Manager for Diagnostics (5/06-10/06) and Outbound Marketing Consultant (1/05-5/06). Show less

Oct 2006 - Oct 2010

Technical Services Senior Scientist

San Carlos, Ca

• Phone/Email Technical Support of RNA Amplification Product (Ribo-SPIA)• Weekly Field Pre-Sales/Technical Seminars and Talks. WebEx Seminars

Apr 2004 - Oct 2004

Senior Applications Scientist In Microarray Division

Molecular Dynamics

Sunnyvale, Ca

• Provided customers with onsite training and support on microarray technologies (pin-spotter, laser scanner and software)• Assisted with system end-to-end testing, representing customer’s point of view in Marketing• Member of the PDP (Product Development Process) team. Providing scientific user requirements input into future products

Aug 1996 - Oct 2000
4 education records

Condie Carmack education

Post-Doctoral Training, Molecular Immunology

Fox Chase Cancer Center

Cancer Research Institute Fellowship NIH Fellowship American Cancer Society Fellowship

FAQ

Frequently asked questions about Condie Carmack

Quick answers generated from the profile data available on this page.

What is Condie Carmack's role at their current company?

Condie Carmack is listed as Owner and Entrepreneur.

Where is Condie Carmack based?

Condie Carmack is based in Greater Houston, United States.

What companies has Condie Carmack worked for?

Condie Carmack has worked for Loxo Oncology, Inc., Vela Diagnostics, Baylor College Of Medicine, Agilent Technologies, and Nugen Technologies.

How can I contact Condie Carmack?

You can use AeroLeads to view verified contact signals for Condie Carmack, including work email, phone, and LinkedIn data when available.

What schools did Condie Carmack attend?

Condie Carmack holds Doctor Of Philosophy (Ph.D.), Pathology/Experimental Pathology from University Of Utah School Of Medicine.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.